Recent advances in the design and applications of amyloid-β peptide aggregation inhibitors for Alzheimer’s disease therapySafura Jokar, Omid Bavi, Mostafa Erfani et al.|Biophysical Reviews|2019Cited by 71
Rational Design, Synthesis, <i>in Vitro</i>, and <i>in Silico</i> Studies of Chlorophenylquinazolin‐4(3<i>H</i>)‐One Containing Different Aryl Acetohydrazides as Tyrosinase InhibitorsMirhamed Hajimiri, Aida Iraji, Mohammad Khosravikia et al.|Chemistry & Biodiversity|2022Cited by 15